For generations, men have been taught that standing to pee is natural, efficient, and even a badge of masculinity. Bathrooms ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

Poster highlights 6-month follow-up data from the ongoing Phase 2 trial of NDV-01 in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety Relmada plans to advance NDV-01, a ...

Bladder stones (vesical calculi) almost always form due to an underlying issue like urinary stasis, obstruction, or foreign bodies. High-risk populations include women with pelvic organ prolapse and ...

Independent 2025 Review Examines How NewEra Protect Combines Kidney Support, Bladder Strength, and Pelvic Floor Recovery. Backed by Clinical-Grade Ingredients and a Verified 60-Day Refund Guarantee.

See disclosure here or remove ads. NDV-01 is a sustained-release, intravesical formulation of gemcitabine and docetaxel designed to enable bladder retention and gradual drug release over 10 days.

FDA feedback supports 2 potential registrational trials - 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized controlled trial in intermediate-risk NMIBC. FDA ...

Dear Dr. Roach: I am 71 and began having urinary issues due to benign prostatic hyperplasia (BPH) many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn't provide any ...

Background Secondary urethral stone although rare, commonly arises from the kidneys, bladder or are seen in patients with urethral stricture. These stones are either found in the posterior or anterior ...

Dr. Raj S. Pruthi appointed CMO at Relmada to lead NDV-01 development for non-muscle invasive bladder cancer. Phase 3 trial planned for 2026. Although positive initial Phase 2 data has been presented, ...